🟢 Nuvation Bio is trading 5.5% up in pre-market as yields ease after Fed decision

Nuvation Bio is trading 5.5% up at $6.10 after a broad pre-market recovery, likely reflecting improved global risk appetite following the Federal Reserve’s decision and easing yields.

• S&P 500, Nasdaq Composite, and Dow futures are all rising more than 0.5% amid firmer overnight equity markets.
• No fresh company-specific announcement dated September 17, 2026, was identified.
• Positive IBTROZI subgroup data were announced September 15, but coverage does not directly attribute the current move to that release.